Skip to main content
Value8 N.V. logo

Value8 N.V. — Investor Relations & Filings

Ticker · VALUE ISIN · NL0010661864 LEI · 724500IOX980PF17L830 AS Financial and insurance activities
Open in API
Filings indexed 503 across all filing types
Latest filing 2011-01-18 Regulatory Filings
Country NL Netherlands
Listing AS VALUE

About Value8 N.V.

https://www.value8.com/

Value8 N.V. is an investment company that focuses on acquiring and managing holdings in small and medium-sized companies. The firm specializes in various investment strategies, including middle-market buyouts, add-on acquisitions, and providing growth capital. Its primary objective is to achieve long-term value creation for its portfolio companies. Value8 maintains a diverse portfolio with investments in sectors such as healthcare services and equipment, IT business and cloud integration, and platforms for independent professionals.

Recent filings

Filing Released Lang Actions
DCA breekt apotheekmarkt open
Regulatory Filings Classification · 95% confidence The document is a press release ("PERSBERICHT") dated January 18, 2011, announcing that Investment company Value8 NV has acquired a 49% stake in De Centrale Apotheek Nederland (DCA). This is a corporate action announcement detailing an investment/acquisition in a healthcare company. This fits best under the category for updates on company fundraising, financing activities, or capital structure changes, which is 'Capital/Financing Update' (CAP). It is not a formal regulatory filing like a 10-K, an earnings release, or a management discussion, but rather a specific corporate transaction announcement.
2011-01-18 Dutch
Value8 NV vergroot belang in Fornix tot 24,91 procent
Share Issue/Capital Change Classification · 99% confidence The document explicitly discusses an increase in shareholding percentage (from 16.3% to 24.91%) in another company (Fornix BioSciences NV) and mentions a mandatory notification to the AFM (Dutch regulator) under Article 5:38 Wft. It also details a simultaneous capital structure change involving the issuance of 73,900 A shares and the repurchase of 73,900 B shares, leading to a change in the total outstanding shares. The core themes are significant share ownership change and capital structure adjustment. The most fitting category is Major Shareholding Notification (MRQ) due to the explicit reporting of crossing a significant ownership threshold (though the threshold itself isn't specified, the notification implies it). However, since it also details a share issuance/repurchase related to the financing of this stake increase, it strongly overlaps with Share Issue/Capital Change (SHA). Given the primary focus is the change in the stake percentage and the regulatory notification (Art. 5:38 Wft), MRQ is the most precise fit for the ownership change aspect, while SHA covers the mechanics of the share issuance/repurchase. Since the text focuses heavily on the resulting ownership percentage and the regulatory filing related to that ownership, MRQ is selected, although SHA is a strong secondary candidate.
2011-01-13 Dutch
Nieuwjaarstoespraak 2011 Value8 NV
AGM Information Classification · 95% confidence The document is titled "Nieuwjaarstoespraak Value8 NV 2011" (New Year's Speech Value8 NV 2011) and is explicitly stated as being delivered by the CEO on January 3, 2011. This type of speech, delivered at the beginning of the year, typically reviews the past year's performance (2010) and outlines expectations for the coming year (2011). It discusses investments, stock performance, and strategic outlook, which aligns with content often found in an Annual Report or an Investor Presentation. However, since it is a speech transcript ('toespraak') delivered at a specific event (New Year's meeting), and it reviews the full prior year's performance, it is most closely related to the content of an Annual Report review or an Investor Presentation. Given the context of reviewing the past year's results and future outlook in a spoken format, it functions similarly to an Investor Presentation (IP) or a segment of the Annual Report/Management Discussion & Analysis. Since it is a transcript of a speech, 'Call Transcript' (CT) is a possibility, but the content is highly strategic and retrospective, fitting better with 'Investor Presentation' (IP) which often includes CEO/management commentary on strategy and results, or 'Management Reports' (MDA) which covers business trends and outlook. Given the CEO's review of the past year's financial achievements (e.g., EPS target met) and future strategy, 'Investor Presentation' (IP) is the most appropriate fit for this type of forward-looking, performance-reviewing material presented to stakeholders, even if it's a speech transcript rather than a slide deck.
2011-01-04 Dutch
Mededeling Value8 NV
Major Shareholding Notification Classification · 99% confidence The document is a short press release ("PERSBERICHT") dated December 3, 2010, announcing that Value8 NV has divested its stake in Naseba due to Naseba's delisting and that Value8 booked a positive result on this investment. This is a specific corporate action related to an investment/divestment. It is not a full annual report (10-K), an earnings release (ER), or a standard management discussion (MDA). It describes a transaction involving the company's assets/investments. Given the options, this type of announcement about a significant transaction (divestment resulting in a gain) fits best under Capital/Financing Update (CAP) as it relates to capital structure changes or significant investment realization, or potentially Regulatory Filings (RNS) if it's a mandatory disclosure in the Netherlands. However, since it details the realization of an investment and the resulting financial impact (positive result), 'CAP' is a strong candidate. Since it is a specific corporate action announcement and not a general regulatory filing fallback, and it concerns the disposition of an investment, I will classify it as a Capital/Financing Update (CAP). The document length is very short (1206 chars), but it contains the core information, not just an announcement of another document, so the RPA rule does not strictly apply here.
2010-12-03 Dutch
SutureAid verkrijgt CE-registratie en start verkoop
Share Issue/Capital Change Classification · 99% confidence The document announces two main pieces of news from Value8 NV: 1) Its investment, SutureAid, received CE registration for a medical product and is starting sales, with Value8 planning additional investment for growth. 2) Value8 NV is issuing 46,000 Class A shares while simultaneously repurchasing 46,000 Class B shares, detailing the resulting capital structure changes. The announcement regarding the share issuance and repurchase directly relates to changes in the company's capital structure and financing activities. This aligns best with the 'Capital/Financing Update' (CAP) category, as it details a specific capital structure adjustment (share swap/issue) intended to finance growth. While it mentions future investment discussions, the core announcement is the immediate capital change.
2010-11-29 Dutch
Value8: Voortgaande groei in derde kwartaal
Earnings Release Classification · 95% confidence The document is titled 'PERSBERICHT' (Press Release) and dated November 15, 2010. It discusses recent operational activities, investment stakes (Buhrs, Fornix BioSciences), progress on corporate restructuring (Dico, EDCC), changes in existing holdings, and crucially, it revises the profit forecast for 2010 upwards ('Prognose voor 2010 naar boven bijgesteld'). This content structure—a summary of recent performance, operational updates, and a revised financial outlook—is characteristic of an Earnings Release (ER), which announces key financial results and highlights for a period (in this case, Q3 performance leading to a full-year forecast revision). It is too detailed for a simple Report Publication Announcement (RPA) but lacks the comprehensive detail of a full Interim Report (IR) or Annual Report (10-K). The language is Dutch, but the function aligns with an ER. Q3 2010
2010-11-15 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.